Valence 로고
인기
로그인
Loading data for BCTXL — first visit, this takes a few seconds.

관심목록에 추가

BriaCell Therapeutics Cor...

NasdaqCM: BCTXL · 실시간 가격 · USD
0.90
-0.18 (-16.67%)
종가 기준: Aug 24, 2026, 2:44 PM

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

BriaCell Therapeutics Corp.(BCTXL) 주가, 분석 및 데이터

-16.67%
매수호가n/a
시가총액n/a
매출 (ttm)n/a
순이익 (ttm)-30.68M
1.52
n/a
n/a
n/a
P/B (ttm)0.27
P/S (ttm)n/a
실적 발표일n/a
매도호가n/a
거래량6,150
평균 거래량 (20일)
시가1.00
전일 종가1.08
일중 범위0.90 - 0.98
52주 범위0.90 - 0.98
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

BCTXL 소개

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an i...

[더 보기]
산업
섹터
IPO 일자 n/a
직원 수 n/a
상장 거래소 NasdaqCM
티커 BCTXL
웹사이트 https://briacell.com
전체 기업 정보

재무 실적

undefined년 BriaCell Therapeutics의 매출은 n/a로, 전년 n/a 대비 undefined% 증가했습니다. 순이익은 n/a로, undefined% 증가했습니다.

재무제표
news image

15시간 전 · InvestorsHub

BriaCell Shares Turn Volatile After Melanoma Vaccine Development Milestone

BriaCell Therapeutics (NASDAQ:BCTX) shares experienced a volatile session on Monday after the biotechnology company announced that its Bria-MEL+ melanoma vaccine candidate had reached an important gen...

news image

1개월 전 · Simply Wall St.

Is CRA International’s New Bria-IMT Role Quietly Redefining Its Healthcare Moat and Pricing Power (CRAI)?

In July 2026, BriaCell Therapeutics Corp. announced it had engaged Charles River Associates (CRA International) and Kaleio, Inc. to support commercial strategy, market access evaluation, and brand pla...

news image

2개월 전 · MT Newswires

BriaCell Presenting Final Phase 2, Ongoing Phase 3 Data at ASCO Meeting

BriaCell Therapeutics (BCT.TO) Monday said it is presenting final Phase 2 data from its Bria-IMT tri

news image

3개월 전 · MT Newswires

BriaCell Therapeutics Completes Manufacturing Bria-PROS+ Clinical Supplies

BriaCell Therapeutics (BCT.TO), down near 1% in U.S. pre-market trade, has completed manufacturing

news image

3개월 전 · MT Newswires

BriaCell Says FDA Clears Way For Bria-BRES+ Phase 1/2a Study

BriaCell Therapeutics (BCT.TO) has received FDA approval to initiate clinical evaluation of its next